← Back to Clinical Trials
Recruiting NCT07107880

NCT07107880 Use of Artificial Intelligence to Assess Trainee Communication Compared to Human Assessment

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07107880
Status Recruiting
Phase
Sponsor Stanford University
Condition Communication Skills
Study Type INTERVENTIONAL
Enrollment 45 participants
Start Date 2025-11-10
Primary Completion 2026-09-14

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 99 Years
Study Type INTERVENTIONAL
Interventions
Communication Assessment through AI and Human

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 45 participants in total. It began in 2025-11-10 with a primary completion date of 2026-09-14.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study will evaluate whether a web-based artificial intelligence platform (AI) (Clinical Mind AI \[CMAI\] Stanford, CA), can assess communication skills in anesthesiology trainees, including residents and fellows, in the setting of disclosing medical errors. All participants will participate in an AI-generated simulation by using the platform remotely, and CMAI will assess trainee performance immediately after the simulation.

Eligibility Criteria

Inclusion Criteria: * Participant's must be 18 years of age or older * Graduate medical trainess such as residents and fellows at all levels of training excluding PGY1 trainees at Department of Anesthesiology, Perioperative, and Pain Medicine at Stanford University * Able to speak and understand English * Willing and able to provide consent to participate in research * Able to participate in Artificial Intelligence communication simulation Exclusion Criteria: * Non-English speaker * unable to provide consent to participate in research * individual with no access to the necessary technology (internet, computer/smart device) required for participating in the digital, voice-based interaction with the AI platform

Contact & Investigator

Central Contact

Asheen Rama, MD

✉ asheen21@stanford.edu

📞 650-723-5728

Principal Investigator

Thomas Caruso, MD, PhD

PRINCIPAL INVESTIGATOR

Stanford University

Frequently Asked Questions

Who can join the NCT07107880 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Communication Skills. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07107880 currently recruiting?

Yes, NCT07107880 is actively recruiting participants. Contact the research team at asheen21@stanford.edu for enrollment information.

Where is the NCT07107880 trial being conducted?

This trial is being conducted at Palo Alto, United States.

Who is sponsoring the NCT07107880 clinical trial?

NCT07107880 is sponsored by Stanford University. The principal investigator is Thomas Caruso, MD, PhD at Stanford University. The trial plans to enroll 45 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology